Cargando…

The Impact of Previsit Contextual Data Collection on Patient-Provider Communication and Patient Activation: Study Protocol for a Randomized Controlled Trial

BACKGROUND: Patient-centered care is respectful of and responsive to individual patient preferences, needs, and values. To provide patient-centered care, clinicians need to know and incorporate patients’ context into their communication and care with patients. Patient contextual data (PCD) encompass...

Descripción completa

Detalles Bibliográficos
Autores principales: Holt, Jeana M, Cusatis, Rachel, Winn, Aaron, Asan, Onur, Spanbauer, Charles, Williams, Joni S, Flynn, Kathryn E, Somai, Melek, Laud, Purushottam, Crotty, Bradley H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542405/
https://www.ncbi.nlm.nih.gov/pubmed/32965223
http://dx.doi.org/10.2196/20309
_version_ 1783591542774038528
author Holt, Jeana M
Cusatis, Rachel
Winn, Aaron
Asan, Onur
Spanbauer, Charles
Williams, Joni S
Flynn, Kathryn E
Somai, Melek
Laud, Purushottam
Crotty, Bradley H
author_facet Holt, Jeana M
Cusatis, Rachel
Winn, Aaron
Asan, Onur
Spanbauer, Charles
Williams, Joni S
Flynn, Kathryn E
Somai, Melek
Laud, Purushottam
Crotty, Bradley H
author_sort Holt, Jeana M
collection PubMed
description BACKGROUND: Patient-centered care is respectful of and responsive to individual patient preferences, needs, and values. To provide patient-centered care, clinicians need to know and incorporate patients’ context into their communication and care with patients. Patient contextual data (PCD) encompass social determinants of health and patients’ needs, values, goals, and preferences relevant to their care. PCD can be challenging to collect as a routine component of the time-limited primary care visit. OBJECTIVE: This study aims to determine if patient-provider communication and patient activation are different for patient users and patient nonusers of an electronic health record (EHR)–integrated PCD tool and assess if the impact of using PCD on patient-provider communication and patient activation differs for Black and White patients. METHODS: We describe a randomized controlled trial of a prospective cohort of non-Hispanic White and Black patients who receive primary care services at a midwestern academic health care system in the United States. We will evaluate whether providing PCD through a consumer informatics tool enhances patient-provider communication, as measured by the Communication Assessment Tool, and we will evaluate patient activation, as measured by the Patient Activation Measure for PCD tool users and nonusers. Furthermore, owing to racial disparities in care and communication, we seek to determine if the adoption and use of the tool might narrow the differences between patient groups. RESULTS: The trial was funded in November 2017 and received local ethics review approval in February 2019. The study began recruitment in April 2019 and enrollment concluded in October 2019 with 301 participants. The analysis was completed in May 2020, and trial results are expected to be published in winter 2020. CONCLUSIONS: Recently, there has been increased attention to the role of health information technology tools to enable patients to collaborate with providers through the sharing of PCD. The adoption of such tools may overcome the barriers of current EHRs by directly engaging patients to submit their contextual data. Effectively, these tools would support the EHR in providing a more holistic understanding of the patient. Research further supports that individuals who have robust digital engagement using consumer informatics tools have higher participation in treatment follow-up and self-care across populations. Therefore, it is critical to investigate interventions that elicit and share patients’ social risks and care preferences with the health care team as a mechanism to improve individualized care and reduce the gap in health outcomes. TRIAL REGISTRATION: ClinicalTrials.gov NCT03766841; https://clinicaltrials.gov/ct2/show/NCT03766841 INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR1-10.2196/20309
format Online
Article
Text
id pubmed-7542405
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-75424052020-10-20 The Impact of Previsit Contextual Data Collection on Patient-Provider Communication and Patient Activation: Study Protocol for a Randomized Controlled Trial Holt, Jeana M Cusatis, Rachel Winn, Aaron Asan, Onur Spanbauer, Charles Williams, Joni S Flynn, Kathryn E Somai, Melek Laud, Purushottam Crotty, Bradley H JMIR Res Protoc Protocol BACKGROUND: Patient-centered care is respectful of and responsive to individual patient preferences, needs, and values. To provide patient-centered care, clinicians need to know and incorporate patients’ context into their communication and care with patients. Patient contextual data (PCD) encompass social determinants of health and patients’ needs, values, goals, and preferences relevant to their care. PCD can be challenging to collect as a routine component of the time-limited primary care visit. OBJECTIVE: This study aims to determine if patient-provider communication and patient activation are different for patient users and patient nonusers of an electronic health record (EHR)–integrated PCD tool and assess if the impact of using PCD on patient-provider communication and patient activation differs for Black and White patients. METHODS: We describe a randomized controlled trial of a prospective cohort of non-Hispanic White and Black patients who receive primary care services at a midwestern academic health care system in the United States. We will evaluate whether providing PCD through a consumer informatics tool enhances patient-provider communication, as measured by the Communication Assessment Tool, and we will evaluate patient activation, as measured by the Patient Activation Measure for PCD tool users and nonusers. Furthermore, owing to racial disparities in care and communication, we seek to determine if the adoption and use of the tool might narrow the differences between patient groups. RESULTS: The trial was funded in November 2017 and received local ethics review approval in February 2019. The study began recruitment in April 2019 and enrollment concluded in October 2019 with 301 participants. The analysis was completed in May 2020, and trial results are expected to be published in winter 2020. CONCLUSIONS: Recently, there has been increased attention to the role of health information technology tools to enable patients to collaborate with providers through the sharing of PCD. The adoption of such tools may overcome the barriers of current EHRs by directly engaging patients to submit their contextual data. Effectively, these tools would support the EHR in providing a more holistic understanding of the patient. Research further supports that individuals who have robust digital engagement using consumer informatics tools have higher participation in treatment follow-up and self-care across populations. Therefore, it is critical to investigate interventions that elicit and share patients’ social risks and care preferences with the health care team as a mechanism to improve individualized care and reduce the gap in health outcomes. TRIAL REGISTRATION: ClinicalTrials.gov NCT03766841; https://clinicaltrials.gov/ct2/show/NCT03766841 INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR1-10.2196/20309 JMIR Publications 2020-09-23 /pmc/articles/PMC7542405/ /pubmed/32965223 http://dx.doi.org/10.2196/20309 Text en ©Jeana M Holt, Rachel Cusatis, Aaron Winn, Onur Asan, Charles Spanbauer, Joni S Williams, Kathryn E Flynn, Melek Somai, Purushottam Laud, Bradley H Crotty. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 23.09.2020. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on http://www.researchprotocols.org, as well as this copyright and license information must be included.
spellingShingle Protocol
Holt, Jeana M
Cusatis, Rachel
Winn, Aaron
Asan, Onur
Spanbauer, Charles
Williams, Joni S
Flynn, Kathryn E
Somai, Melek
Laud, Purushottam
Crotty, Bradley H
The Impact of Previsit Contextual Data Collection on Patient-Provider Communication and Patient Activation: Study Protocol for a Randomized Controlled Trial
title The Impact of Previsit Contextual Data Collection on Patient-Provider Communication and Patient Activation: Study Protocol for a Randomized Controlled Trial
title_full The Impact of Previsit Contextual Data Collection on Patient-Provider Communication and Patient Activation: Study Protocol for a Randomized Controlled Trial
title_fullStr The Impact of Previsit Contextual Data Collection on Patient-Provider Communication and Patient Activation: Study Protocol for a Randomized Controlled Trial
title_full_unstemmed The Impact of Previsit Contextual Data Collection on Patient-Provider Communication and Patient Activation: Study Protocol for a Randomized Controlled Trial
title_short The Impact of Previsit Contextual Data Collection on Patient-Provider Communication and Patient Activation: Study Protocol for a Randomized Controlled Trial
title_sort impact of previsit contextual data collection on patient-provider communication and patient activation: study protocol for a randomized controlled trial
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542405/
https://www.ncbi.nlm.nih.gov/pubmed/32965223
http://dx.doi.org/10.2196/20309
work_keys_str_mv AT holtjeanam theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT cusatisrachel theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT winnaaron theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT asanonur theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT spanbauercharles theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT williamsjonis theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT flynnkathryne theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT somaimelek theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT laudpurushottam theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT crottybradleyh theimpactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT holtjeanam impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT cusatisrachel impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT winnaaron impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT asanonur impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT spanbauercharles impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT williamsjonis impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT flynnkathryne impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT somaimelek impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT laudpurushottam impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial
AT crottybradleyh impactofprevisitcontextualdatacollectiononpatientprovidercommunicationandpatientactivationstudyprotocolforarandomizedcontrolledtrial